Adaptive Biotechnologies Corp
NASDAQ:ADPT
Adaptive Biotechnologies Corp
Total Receivables
Adaptive Biotechnologies Corp
Total Receivables Peer Comparison
Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
Total Receivables
$42m
|
CAGR 3-Years
29%
|
CAGR 5-Years
59%
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Total Receivables
$9.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
18%
|
CAGR 10-Years
17%
|
|
Danaher Corp
NYSE:DHR
|
Total Receivables
$3.4B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
0%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Total Receivables
$650.3m
|
CAGR 3-Years
4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
4%
|
|
Agilent Technologies Inc
NYSE:A
|
Total Receivables
$1.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
9%
|
CAGR 10-Years
4%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Total Receivables
$3.4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
7%
|
CAGR 10-Years
14%
|
See Also
What is Adaptive Biotechnologies Corp's Total Receivables?
Total Receivables
42m
USD
Based on the financial report for Mar 31, 2024, Adaptive Biotechnologies Corp's Total Receivables amounts to 42m USD.
What is Adaptive Biotechnologies Corp's Total Receivables growth rate?
Total Receivables CAGR 5Y
59%
Over the last year, the Total Receivables growth was 36%. The average annual Total Receivables growth rates for Adaptive Biotechnologies Corp have been 29% over the past three years , 59% over the past five years .